These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21867751)

  • 1. (1)H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease.
    Verwaest KA; Vu TN; Laukens K; Clemens LE; Nguyen HP; Van Gasse B; Martins JC; Van Der Linden A; Dommisse R
    Biochim Biophys Acta; 2011 Nov; 1812(11):1371-9. PubMed ID: 21867751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF and serum metabolic profile of patients with Huntington's chorea: a study by high resolution proton NMR spectroscopy and HPLC.
    Nicoli F; Vion-Dury J; Maloteaux JM; Delwaide C; Confort-Gouny S; Sciaky M; Cozzone PJ
    Neurosci Lett; 1993 May; 154(1-2):47-51. PubMed ID: 8361646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain energy metabolism in a sub-acute rat model of manganese neurotoxicity: an ex vivo nuclear magnetic resonance study using [1-13C]glucose.
    Zwingmann C; Leibfritz D; Hazell AS
    Neurotoxicology; 2004 Jun; 25(4):573-87. PubMed ID: 15183011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic changes in quinolinic acid-lesioned rat striatum detected non-invasively by in vivo (1)H NMR spectroscopy.
    Tkác I; Keene CD; Pfeuffer J; Low WC; Gruetter R
    J Neurosci Res; 2001 Dec; 66(5):891-8. PubMed ID: 11746416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRL/lpr mice have alterations in brain metabolism as shown with [1H-13C] NMR spectroscopy.
    Alexander JJ; Zwingmann C; Quigg R
    Neurochem Int; 2005 Jul; 47(1-2):143-51. PubMed ID: 15893408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice.
    Jenkins BG; Klivenyi P; Kustermann E; Andreassen OA; Ferrante RJ; Rosen BR; Beal MF
    J Neurochem; 2000 May; 74(5):2108-19. PubMed ID: 10800956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton magnetic resonance spectroscopy of cerebrospinal fluid in neurodegenerative disease: indication of glial energy impairment in Huntington chorea, but not Parkinson disease.
    Gårseth M; Sonnewald U; White LR; Rød M; Zwart JA; Nygaard O; Aasly J
    J Neurosci Res; 2000 Jun; 60(6):779-82. PubMed ID: 10861790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early deficits in glycolysis are specific to striatal neurons from a rat model of huntington disease.
    Gouarné C; Tardif G; Tracz J; Latyszenok V; Michaud M; Clemens LE; Yu-Taeger L; Nguyen HP; Bordet T; Pruss RM
    PLoS One; 2013; 8(11):e81528. PubMed ID: 24303051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression.
    Mochel F; Charles P; Seguin F; Barritault J; Coussieu C; Perin L; Le Bouc Y; Gervais C; Carcelain G; Vassault A; Feingold J; Rabier D; Durr A
    PLoS One; 2007 Jul; 2(7):e647. PubMed ID: 17653274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic profiling studies on the toxicological effects of realgar in rats by (1)H NMR spectroscopy.
    Wei L; Liao P; Wu H; Li X; Pei F; Li W; Wu Y
    Toxicol Appl Pharmacol; 2009 Feb; 234(3):314-25. PubMed ID: 19073202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic profiling for the identification of Huntington biomarkers by on-line solid-phase extraction capillary electrophoresis mass spectrometry combined with advanced data analysis tools.
    Pont L; Benavente F; Jaumot J; Tauler R; Alberch J; Ginés S; Barbosa J; Sanz-Nebot V
    Electrophoresis; 2016 Mar; 37(5-6):795-808. PubMed ID: 26685060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's disease.
    Reynolds NC; Prost RW; Mark LP
    Brain Res; 2005 Jan; 1031(1):82-9. PubMed ID: 15621015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialysis modality-dependent changes in serum metabolites: accumulation of inosine and hypoxanthine in patients on haemodialysis.
    Choi JY; Yoon YJ; Choi HJ; Park SH; Kim CD; Kim IS; Kwon TH; Do JY; Kim SH; Ryu DH; Hwang GS; Kim YL
    Nephrol Dial Transplant; 2011 Apr; 26(4):1304-13. PubMed ID: 20844182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is brain lactate increased in Huntington's disease?
    Martin WR; Wieler M; Hanstock CC
    J Neurol Sci; 2007 Dec; 263(1-2):70-4. PubMed ID: 17655868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic and type 1 cannabinoid receptor imaging of a transgenic rat model in the early phase of Huntington disease.
    Casteels C; Vandeputte C; Rangarajan JR; Dresselaers T; Riess O; Bormans G; Maes F; Himmelreich U; Nguyen H; Van Laere K
    Exp Neurol; 2011 Jun; 229(2):440-9. PubMed ID: 21459091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioenergetic dysfunction in Huntington's disease human cybrids.
    Ferreira IL; Cunha-Oliveira T; Nascimento MV; Ribeiro M; Proença MT; Januário C; Oliveira CR; Rego AC
    Exp Neurol; 2011 Sep; 231(1):127-34. PubMed ID: 21684277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary Metabolomic Approach Provides New Insights into Distinct Metabolic Profiles of Glutamine and N-Carbamylglutamate Supplementation in Rats.
    Liu G; Cao W; Fang T; Jia G; Zhao H; Chen X; Wu C; Wang J
    Nutrients; 2016 Aug; 8(8):. PubMed ID: 27527211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo 1H NMR spectroscopy.
    Tkac I; Dubinsky JM; Keene CD; Gruetter R; Low WC
    J Neurochem; 2007 Mar; 100(5):1397-406. PubMed ID: 17217418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased glucose metabolism and ATP level in brain tissue of Huntington's disease transgenic mice.
    Oláh J; Klivényi P; Gardián G; Vécsei L; Orosz F; Kovacs GG; Westerhoff HV; Ovádi J
    FEBS J; 2008 Oct; 275(19):4740-55. PubMed ID: 18721135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microstructural changes observed with DKI in a transgenic Huntington rat model: evidence for abnormal neurodevelopment.
    Blockx I; De Groof G; Verhoye M; Van Audekerke J; Raber K; Poot D; Sijbers J; Osmand AP; Von Hörsten S; Van der Linden A
    Neuroimage; 2012 Jan; 59(2):957-67. PubMed ID: 21906685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.